Healthcare >> Analyst Interviews >> March 9, 2009
Claude Camire is senior biotech analyst at Paradigm Capital Inc. He has been an
analyst for nine years for various firms including Dundee Securities and Groome
Capital. He has also worked for more than 15 years for various pharmaceutical
companies such as Abbott Laboratories, Sanofi-Aventis, Biochem Pharma (now part
of Shire Pharmaceutical Inc.) and ProMetic Life Sciences in various functions.
He graduated from the University of Sherbrooke and obtained his B Comm with a
major in Finance. Profile
Mr. Camire: Right now, we are focusing on healthcare companies that generate
revenues or are close to; we are trying
